ArticleMaterials today. Bio2025

Lipid nanoparticle-mediated mRNA/siRNA dual-bioengineered dendritic cell vaccines combined of PD-1/PD-L1 blockade for boosting tumor immunotherapy.

Dong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.